SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.795
+0.005 (0.13%)
Mar 9, 2026, 3:03 PM EDT - Market open
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $180.67 million as of March 9, 2026. Its market cap has increased by 903.87% in one year.
Market Cap
180.67M
Enterprise Value
77.40M
1-Year Change
903.87%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $180.67M, an increase of 38.17%. That is a compound annual growth rate of 6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 180.43M | 1.34% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 188.04M |
| ProQR Therapeutics | 187.51M |
| Molecular Partners AG | 187.40M |
| Kalaris Therapeutics | 183.66M |
| Heron Therapeutics | 182.24M |
| Cartesian Therapeutics | 178.12M |
| Nkarta | 177.57M |
| Tiziana Life Sciences | 177.40M |